Retina Research Institute

At New England Retina Consultants, we are committed to providing the highest quality retina care to our patients. To accommodate a growing and important aspect of exceptional retinal care, we will soon begin construction on a new facility, completely dedicated to retinal investigations.

The Retina Research Institute at New England Retina Consultants has a strong commitment to the advancement of treatments for retinal conditions. If you or someone you know is interested in more information about our clinical trial program, please contact Leah Persky, 413-788-6044.

Enrolling Trials
OPH2003 (Ophthotech)- A phase 2/3 randomized, double-masked, controlled trial to assess the safety and efficacy of intravitreous administration of Zimura (Anti-C5 apatmer) in subjects with geographic atrophy secondary to dry age-related macular degeneration

TOPAZ (Clearside Biomedical)- A randomized, masked, controlled trial to study the safety and efficacy of suprachoroidal CLS-TA in combination with an intravitreal anti-VEGF agent in subjects with retinal vein occlusion

Renexus (Neurotech): A phase III multicenter randomized, sham controlled study to determine the safety and efficacy of Renexus in macular telangiectasia type 2

MACTEL (Neurotech): A natural history observation and registry study of macular telangiectasia type 2; the mactel study

Ora, Inc – OCT-angiography imaging device non-inferiority study

Completed Trials

Apex Study (Tyrogenex) – A randomized, double-masked, placebo-controlled, dose-finding, non-inferiority study of X-82 plus prn ivt anti-VEGF compared to prn ivt anti-VEGF monotherapy in neovascular AMD

Eyetech EOP1004 (Macugen)
Genentech MARINA (Lucentis)
Genentech ANCHOR (Lucentis)
Genentech PIER (Lucentis)
Genentech HORIZON (Lucentis)
Genentech SAILOR (Lucentis)
Allergan Posurdex 206207-001 (Ozurdex)
Allergan Posurdex 206207-009 (Ozurdex)
Regeneron READ 2 (Eylea)
Genentech SEVEN-UP (Lucentis)